Trials / Completed
CompletedNCT03348423
Evaluation of DEX-IN During Outpatient Procedures
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Evaluation of the Efficacy and Safety of DEX-IN Following Painful Outpatient Procedures
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Baudax Bio · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the analgesic efficacy of DEX-IN compared with placebo and active control (fentanyl), in subjects undergoing painful outpatient and office based procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DEX-IN | IN Dexmedetomidine + IV placebo |
| DRUG | Fentanyl | IN Placebo + IV Fentanyl |
| DRUG | Placebo | IN Placebo + IV Placebo |
Timeline
- Start date
- 2017-11-15
- Primary completion
- 2018-01-18
- Completion
- 2018-01-18
- First posted
- 2017-11-20
- Last updated
- 2023-05-25
- Results posted
- 2023-05-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03348423. Inclusion in this directory is not an endorsement.